SCHEMBL23301488

SCHEMBL23301488

O=C(OCc1ccccc1)N1CCC(Oc2cccc(Br)c2)CC1

nearest known ligand 0.57

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 3/20 0.57
NPC1 O15118 2/20 0.57
RAB9A P51151 2/20 0.57
CYP2C19 P33261 1/20 0.55
LNPEP Q9UIQ6 1/20 0.51
MEN1 O00255 1/20 0.49
KMT2A Q03164 1/20 0.49
NPSR1 Q6W5P4 1/20 0.49
OPRK1 P41145 1/20 0.48
PDE4B Q07343 1/20 0.48
GRIN2B Q13224 7/20 0.47
HTT P42858 1/20 0.47
GPR119 Q8TDV5 3/20 0.47
CYP2D6 P10635 4/20 0.47
CYP2C9 P11712 4/20 0.47
MAOB P27338 1/20 0.46
CYP3A4 P08684 3/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29942602 1.00 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP
SCHEMBL2947696 0.87 SMN1; SMN2 (0.59) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP
SCHEMBL12660048 0.86 SMN1; SMN2 (0.57) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP
SCHEMBL21854741 0.86 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP
SCHEMBL30797177 0.86 SMN1; SMN2 (0.54) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP
SCHEMBL3399260 0.82 GPR119 (0.47) SMN1; SMN2LNPEPMEN1KMT2AGPR119
SCHEMBL15637209 0.81 SLC6A2 (0.50) MEN1KMT2AOPRK1
SCHEMBL31198753 0.81 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19MEN1
SCHEMBL30120062 0.81 SMN1; SMN2 (0.60) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP
SCHEMBL309611 0.81 SMN1; SMN2 (0.55) SMN1; SMN2NPC1RAB9ACYP2C19LNPEP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114728936-A Bifunctional compounds for the treatment of cancer 豪夫迈·罗氏有限公司 2022-07-08 CN disclosed
WO-2021083949-A1 BIFUNCTIONAL COMPOUNDS FOR THE TREATMENT OF CANCER F. HOFFMANN-LA ROCHE AG (CH) 2021-05-06 WO disclosed